NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)

RecruitingN/A

Sponsor: University of California, San Francisco

Conditions: Metastatic Breast Cancer, Lobular Breast Carcinoma

Interventions: Blood Specimen

Countries: United States

This is a prospective observational registry for patients with invasive lobular carcinoma (ILC) of the breast. After the first 1cohort is enrolled, the collected data will be utilized to develop an ILC specific response assessment tool.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

1. Histologically confirmed invasive lobular carcinoma. Mixed lobular/ductal cancer is allowed.
2. Age \>=18 years
3. Any receptor subtype.
4. Ability to understand a written informed consent document, and the willingness to sign it.

Exclusion Criteria:

1. Stage I-III breast cancer.
2. Lack of lobular histology on tumor biopsy.
3. Other active cancer (prior treated cancer with no current evidence of disease is allowed).

Locations (4)

San Diego, California, United States
San Francisco, California, United States
Philadelphia, Pennsylvania, United States
Houston, Texas, United States